our mission

To develop and commercialize self-administered parenteral medicines that optimize clinical benefits with enhanced cost effective health outcomes

news / press releases

  • 3 December 2014

    Antares Pharma to Present at the 25th Annual Oppenheimer Healthcare Conference
  • 25 November 2014

    Antares Pharma to Present at the 26th Annual Piper Jaffray Healthcare Conference
  • 18 November 2014

    Antares Pharma Appoints James E. Fickenscher, Senior Vice President, Chief Financial Officer
  • 6 November 2014

    Antares Pharma Reports Third Quarter 2014 Operating and Financial Results
  • 3 November 2014

    Antares Pharma Announces Last Patient Enrolled in Phase 3 Quickshot Study Evaluating Testosterone-Deficient Adult Males
  • 30 October 2014

    Antares Pharma to Host Third Quarter 2014 Operating and Financial Results Conference Call

latest products & technology

 

Otrexup (methotrexate) injection for subcutaneous use only.

Learn More >>